Synthesis of 1-indolyl substituted β-carboline natural products and discovery of antimalarial and cytotoxic activities

Show simple item record

dc.contributor.author Liew, Lydia en
dc.contributor.author Fleming, JM en
dc.contributor.author Longeon, A en
dc.contributor.author Mouray, E en
dc.contributor.author Florent, I en
dc.contributor.author Bourguet-Kondracki, M-L en
dc.contributor.author Copp, Brent en
dc.date.accessioned 2017-10-16T03:53:01Z en
dc.date.available 2014-05-19 en
dc.date.issued 2014-08-19 en
dc.identifier.citation Tetrahedron, 70(33):4910-4920, 19 Aug 2014 en
dc.identifier.issn 0040-4020 en
dc.identifier.uri http://hdl.handle.net/2292/36093 en
dc.description.abstract A series of 1-indolyl substituted β-carbolines including the natural products hyrtiosulawesine, pityriacitrin and pityriacitrin B were prepared via Pictet–Spengler condensation—oxidation strategy from the corresponding indolyl-acetaldehydes and substituted tryptamines. Efforts to prepare the C-1 methylene-linked β-carboline analogues for structure–activity relationship studies were unsuccessful. Biological evaluation revealed two analogues (5 and 41) to exhibit weak inhibition of phospholipase A2 (IC50 171 and 131 μM, respectively), two to act as antioxidants (3 and 43), and 12 analogues with activity towards a chloroquine-resistant strain (FcB1) of Plasmodium falciparum (IC50 1.0–23 μM). Testing against a panel of 60 human tumour cell lines revealed a general lack of cytotoxic effect for most of the compounds with the exception of β-carboline 42 exhibiting modest antileukaemic activity towards the HL-60(TB) cell line (LC50 4.2 μM). In addition, two novel structures (30 and 32) resulting from aldol condensation followed by Pictet–Spengler cyclisation displayed cytotoxicity with pronounced subpanel specificities towards colon cancer (COLO 205 and HCC-2998) cell lines. en
dc.language English en
dc.publisher Elsevier en
dc.relation.ispartofseries Tetrahedron en
dc.rights Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. Details obtained from http://sherpa.ac.uk/romeo/issn/0040-4020/ https://www.elsevier.com/about/our-business/policies/sharing en
dc.rights.uri https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm en
dc.title Synthesis of 1-indolyl substituted β-carboline natural products and discovery of antimalarial and cytotoxic activities en
dc.type Journal Article en
dc.identifier.doi 10.1016/j.tet.2014.05.068 en
pubs.issue 33 en
pubs.begin-page 4910 en
pubs.volume 70 en
dc.rights.holder Copyright: Elsevier en
pubs.author-url http://www.sciencedirect.com/science/article/pii/S0040402014007625 en
pubs.end-page 4920 en
pubs.publication-status Published en
dc.rights.accessrights http://purl.org/eprint/accessRights/RestrictedAccess en
pubs.subtype Article en
pubs.elements-id 444197 en
pubs.org-id Medical and Health Sciences en
pubs.org-id Medical Sciences en
pubs.org-id Auckland Cancer Research en
pubs.org-id Science en
pubs.org-id Chemistry en
pubs.org-id Science Research en
pubs.org-id Maurice Wilkins Centre (2010-2014) en
dc.identifier.eissn 1464-5416 en
pubs.record-created-at-source-date 2017-10-16 en
pubs.online-publication-date 2014-05-24 en


Files in this item

Find Full text

This item appears in the following Collection(s)

Show simple item record

Share

Search ResearchSpace


Browse

Statistics